State of Wisconsin Investment Board
ENTA icon

State of Wisconsin Investment Board’s Enanta Pharmaceuticals ENTA Stock Holding History

State of Wisconsin Investment Board’s Portfolio ENTA Stock Details ENTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$235K Hold
18,608
– – ﹤0.01% 2305
2025
Q4 		$293K Buy
+18,608
New +$236K ﹤0.01% 2174
2024
Q1 		– Sell
-45,900
Closed -$432K – 2275
2023
Q4 		$432K Buy
45,900
+34,070
+288% +$317K ﹤0.01% 1832
2023
Q3 		$132K Sell
11,830
-10,154
-46% -$164K ﹤0.01% 2329
2023
Q2 		$470K Buy
21,984
+676
+3% +$19.9K ﹤0.01% 1851
2023
Q1 		$862K Buy
21,308
+2,553
+14% +$122K ﹤0.01% 1536
2022
Q4 		$872K Sell
18,755
-1,212
-6% -$55.3K ﹤0.01% 1569
2022
Q3 		$1.04M Buy
19,967
+63
+0.3% +$3.68K ﹤0.01% 1528
2022
Q2 		$941K Sell
19,904
-5,996
-23% -$325K ﹤0.01% 1671
2022
Q1 		$1.84M Sell
25,900
-4,000
-13% -$260K ﹤0.01% 1521
2021
Q4 		$2.24M Buy
29,900
+4,000
+15% +$314K ﹤0.01% 1254
2021
Q3 		$1.47M Hold
25,900
– – ﹤0.01% 1350
2021
Q2 		$1.14M Hold
25,900
– – ﹤0.01% 1414
2021
Q1 		$1.28M Sell
25,900
-1,300
-5% -$64.8K ﹤0.01% 1307
2020
Q4 		$1.15M Sell
27,200
-3,400
-11% -$150K ﹤0.01% 1292
2020
Q3 		$1.4M Buy
30,600
+1,000
+3% +$48.5K ﹤0.01% 1226
2020
Q2 		$1.49M Buy
29,600
+200
+0.7% +$10.3K ﹤0.01% 1174
2020
Q1 		$1.51M Buy
29,400
+3,800
+15% +$203K 0.01% 1129
2019
Q4 		$1.58M Hold
25,600
– – ﹤0.01% 1164
2019
Q3 		$1.54M Buy
25,600
+1,200
+5% +$89.1K ﹤0.01% 1061
2019
Q2 		$2.06M Buy
24,400
+1,900
+8% +$171K 0.01% 1014
2019
Q1 		$2.15M Buy
22,500
+5,200
+30% +$466K 0.01% 990
2018
Q4 		$1.23M Buy
17,300
+200
+1% +$15.3K ﹤0.01% 1077
2018
Q3 		$1.46M Hold
17,100
– – ﹤0.01% 1102
2018
Q2 		$1.98M Sell
17,100
-12,349
-42% -$1.23M 0.01% 997
2018
Q1 		$2.38M Buy
29,449
+18,449
+168% +$1.42M 0.01% 947
2017
Q4 		$645K Hold
11,000
– – ﹤0.01% 1239
2017
Q3 		$515K Hold
11,000
– – ﹤0.01% 1287
2017
Q2 		$396K Buy
+11,000
New +$352K ﹤0.01% 1333

Other funds holding ENTA

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
SSC
Spruce Street Capital New York $416M AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

State of Wisconsin Investment Board's ENTA Position: Q1 2026 in Review

State of Wisconsin Investment Board held its Enanta Pharmaceuticals (ENTA) position steady in Q1 2026 at 18,608 shares worth $235K. The position accounts for ﹤0.01% of the portfolio, ranked #2305.

State of Wisconsin Investment Board first reported a position in ENTA in Q2 2017 and has held it in 29 quarters since. The position peaked at $2.38M in Q1 2018. 133 funds tracked by Wall St. Rank hold ENTA as of Q1 2026.

  • State of Wisconsin Investment Board held 18,608 shares of Enanta Pharmaceuticals worth $235K as of Q1 2026.
  • State of Wisconsin Investment Board left its Enanta Pharmaceuticals share count unchanged in Q1 2026.
  • Enanta Pharmaceuticals made up ﹤0.01% of State of Wisconsin Investment Board's portfolio in Q1 2026, its #2305 holding.
  • State of Wisconsin Investment Board first reported a position in Enanta Pharmaceuticals in Q2 2017 and has held it in 29 quarters since.
  • State of Wisconsin Investment Board's Enanta Pharmaceuticals position peaked at $2.38M in Q1 2018.
  • 133 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q1 2026.

Based on State of Wisconsin Investment Board's 13F filing for Q1 2026, filed 15 May 2026.